Allopurinol

别嘌呤

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameAllopurinol
Drug Alias Name别嘌醇别嘌呤醇异嘌呤醇LopurinZyloric +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionXanthine dehydrogenase inhibitors
TargetsXanthine dehydrogenase
Therapy Area/IndicationsDepressionInflammationHyperuricemia +[10] 
Global Approved IndicationsHyperuricemiaNephrolithiasisGout
Approved Indications in ChinaHyperuricemiaNephrolithiasisGout
Original Approved Country/TerritoryUnited States
Original Approved Date1966/08/19
Country/TerritoryBelgiumUnited StatesMexico +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSebela Ireland Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCasper Pharma LlcUniversity Of MissouriTanta University +[4] 
Inactive CompaniesInstituto Nacional De Cardiologia Ignacio ChavezIncor Heart InstituteAdvancell Advanced In Vitro Cell Technologies Sa +[5] 
Active IndicationsDepressionHyperuricemiaDiabetes Mellitus, Type 2 +[6] 
Inactive IndicationsInflammationHand-Foot SyndromeAngina Pectoris +[4] 

Other Information

ATC CodeM04AA01
Related LinksWikipediaDrugBankKEGG